Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

257183.pdf (688.05 KB)

Document type

Article

Version

Published version

Publication date

2022-10-19

Publication license

cc-by-nc (c) Cillóniz, Catia et al., 2022
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/209181

Respiratory viruses: their importance and lessons learned from COVID-19

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.1183/16000617.0051-2022

Abstract

Respiratory virus infection can cause severe illnesses capable of inducing acute respiratory failure that can progress rapidly to acute respiratory distress syndrome (ARDS). ARDS is related to poor outcomes, especially in individuals with a higher risk of infection, such as the elderly and those with comorbidities, i.e. obesity, asthma, diabetes mellitus and chronic respiratory or cardiovascular disease. Despite this, effective antiviral treatments available for severe viral lung infections are scarce. The coronavirus disease 2019 (COVID-19) pandemic demonstrated that there is also a need to understand the role of airborne transmission of respiratory viruses. Robust evidence supporting this exists, but better comprehension could help implement adequate measures to mitigate respiratory viral infections. In severe viral lung infections, early diagnosis, risk stratification and prognosis are essential in managing patients. Biomarkers can provide reliable, timely and accessible information possibly helpful for clinicians in managing severe lung viral infections. Although respiratory viruses highly impact global health, more research is needed to improve care and prognosis of severe lung viral infections. In this review, we discuss the epidemiology, diagnosis, clinical characteristics, management and prognosis of patients with severe infections due to respiratory viruses.

Subject

Virus, Infeccions respiratòries, COVID-19, Insuficiència respiratòria, Medicaments antivírics, Marcadors bioquímics

Subject (English)

Viruses, Respiratory infections, COVID-19, Respiratory insufficiency, Antiviral agents, Biochemical markers

Citation

Collections

Articles publicats en revistes (Fonaments Clínics)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citation

CILLÓNIZ, Catia, et al. Respiratory viruses: their importance and lessons learned from COVID-19. 2022. vol. 31. Vol. 166. ISSN 0905-9180. [consulted: 18 of August of 2026]. Available at: https://hdl.handle.net/2445/209181

Export metadata

JSON - METS

Share record